Advertisement

Documenta Ophthalmologica

, Volume 138, Issue 2, pp 77–84 | Cite as

Pattern visual evoked potential in hypothyroid patients

  • Abbas Azimi
  • Shokoufeh Bonakdaran
  • Javad Heravian
  • Parvin layegh
  • Negareh Yazdani
  • Maryam AlborziEmail author
Original Research Article

Abstract

Purpose

To investigate the functional integrity of visual pathway in hypothyroid patients by pattern visual evoked potential (PVEP).

Methods

We enrolled 36 female patients with history of hypothyroidism (18 overt and 18 subclinical) aged 20 to 60 years and 36 healthy women of similar age (control group). All subjects had a complete ophthalmic examination. For VEP testing, subjects were exposed to checks subtending a visual angle of 15 and 60 min of arc.

Results

For the 15 min of arc check size, the mean P100 latency was significantly delayed (113 milliseconds (ms)) and amplitude significantly reduced (9.2 microvolts (µv)) in the hypothyroidism group compared with controls (109.6 ms and 11.6 µv, respectively). For this 15′ check size, the group differences were related to significantly increased latency and reduced amplitude of responses in the group with overt hypothyroidism compared with controls. There was no difference between the groups (hypothyroid vs control) with 60 min of arc check size. There was a significant correlation between severity of the disease and PVEP component.

Conclusions

In conclusion, low levels of circulating hypothyroid hormone are associated with delay in the pattern VEP to small check sizes. This CNS involvement worsens in patients with greater severity and duration of hypothyroidism.

Keywords

Hypothyroidism Visual evoked potential Central nervous system Visual pathway 

Notes

Acknowledgements

We thank the research vice-chancellor of Mashhad University of Medical Sciences for supporting this study. The results described in this paper were of a MSc Optometry thesis.

Funding

No funding was received for this research

Compliance with ethical standards

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership or other equity interest; and expert testimony or patent licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Statement of human rights

This study was approved (code 89956 and number 511/1142) by Research Council and Ethics Committee at Mashhad University of Medical Science and the research was carried out in agreement with the principle of the Declaration of Helsinki. This study was conducted after getting written informed consent from all participants.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Statement on the welfare of animals

This article does not contain any studies with animals performed by any of the authors.

References

  1. 1.
    Ladenson PW, Stakes JW, Ridgway EC (1984) Reversible alteration of the visual evoked potential in hypothyroidism. Am J Med 77(6):1010–1014CrossRefGoogle Scholar
  2. 2.
    Surks MI et al (2004) Subclinical thyroid disease. JAMA J Am Med Assoc 291(2):228CrossRefGoogle Scholar
  3. 3.
    Cooper DS (2001) Subclinical hypothyroidism. N Engl J Med 345(4):260–265CrossRefGoogle Scholar
  4. 4.
    Versura P, Campos EC (2010) The ocular surface in thyroid diseases. Curr Opin Allergy Clin Immunol 10(5):486–492CrossRefGoogle Scholar
  5. 5.
    Avramides A et al (1992) Visual evoked potentials in hypothyroid and hyperthyroid patients before and after achievement of euthyroidism. J Endocrinol Invest 15(10):749–753CrossRefGoogle Scholar
  6. 6.
    Khedr EM, El Toony LF, Tarkhan MN, Abdella G (2000) Peripheral and central nervous system alterations in hypothyroidism: electrophysiological findings. Neuropsychobiology 41(2):88–94CrossRefGoogle Scholar
  7. 7.
    Tamburini G et al (1998) Visual evoked potentials in hypothyroidism: a long-term evaluation. Electromyogr Clin Neurophysiol 38(4):201–205Google Scholar
  8. 8.
    Misra S, Sinha RS, Jain DC, Chakravorty B (1996) Visual evoked potential (VEP)–dependable marker for CNS affection in thyroid diseases. J Assoc Phys India 44(2):123–126Google Scholar
  9. 9.
    Nazliel B, Akbay E, Irkec C, Yetkin I, Ersoy R, Toruner F (2002) Pattern visual evoked potential (PVEP) evaluation in hypothyroidism. J Endocrinol Invest 25(11):955–958CrossRefGoogle Scholar
  10. 10.
    Holder GE, Condon JR (1989) Pattern visual evoked potentials and pattern electroretinograms in hypothyroidism. Doc Ophthalmol 73(2):127–131CrossRefGoogle Scholar
  11. 11.
    Osterweil D, Syndulko K, Cohen SN, Pettler-Jennings PD (1992) Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 40:325–335CrossRefGoogle Scholar
  12. 12.
    American Clinical Neurophysiology (2006) Guideline 5: guidelines for standard electrode position nomenclature. J Clin Neurophysiol 23:107–110CrossRefGoogle Scholar
  13. 13.
    Mastaglia FL, Black JL, Collins DW, Gutteridge DH, Yuen RW (1978) Slowing of conduction in visual pathway in hypothyroidism. Lancet 1(8060):387–388CrossRefGoogle Scholar
  14. 14.
    Huang TS, Chang YC, Lee SH, Chen FW, Chopra IJ (1989) Visual, brainstem auditory and somatosensory evoked potential abnormalities in thyroid disease. Thyroidology 1(3):137–142Google Scholar
  15. 15.
    Abbott RJ, O’Malley BP, Barnett DB, Timson L, Rosenthal FD (1983) Central and peripheral nerve conduction in thyroid dysfunction: the influence of L-thyroxine therapy compared with warming upon the conduction abnormalities of primary hypothyroidism. Clin Sci 64(6):617–622CrossRefGoogle Scholar
  16. 16.
    Caturegli P, Kimura H, Rocchi R, Rose NR (2007) Autoimmune thyroid diseases. Curr Opin Rheumatol 19(1):44–48CrossRefGoogle Scholar
  17. 17.
    Fairweather D, Frisancho-Kiss S, Rose NR (2008) Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 173(3):600–609CrossRefGoogle Scholar
  18. 18.
    Flynn RWV, MacDonald TM, Morris AD, Jung RT, Leese GP (2004) The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. J Clin Endocrinol Metab 89(8):3879–3884CrossRefGoogle Scholar
  19. 19.
    Odom JV et al (2016) ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol 133(1):1–9.  https://doi.org/10.1007/s10633-016-9553-y CrossRefGoogle Scholar
  20. 20.
    Nemni R et al (1987) Polyneuropathy in hypothyroidism: clinical, electrophysiological and morphological findings in four cases. J Neurol Neurosurg Psychiatry 50(11):1454–1460CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Abbas Azimi
    • 1
    • 2
  • Shokoufeh Bonakdaran
    • 3
  • Javad Heravian
    • 1
    • 2
  • Parvin layegh
    • 4
  • Negareh Yazdani
    • 1
    • 2
  • Maryam Alborzi
    • 1
    Email author
  1. 1.Department of Optometry, School of Paramedical SciencesMashhad University of Medical SciencesMashhadIran
  2. 2.Refractive Errors Research Center, School of Paramedical SciencesMashhad University of Medical SciencesMashhadIran
  3. 3.Endocrine Research Center, Ghaem HospitalMashhad University of Medical SciencesMashhadIran
  4. 4.Endocrine Research Center, Imam Reza HospitalMashhad University of Medical SciencesMashhadIran

Personalised recommendations